ANGELIQUE DIAZ: Open Payments
NPI 1245878024 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 58 payments from 20 companies in 2025. Trend: 2023 $1,193 · 2024 $952 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $222 |
| PFIZER INC. | 7 | $141 |
| AstraZeneca Pharmaceuticals LP | 7 | $126 |
| Lilly USA, LLC | 4 | $76 |
| Abbott Laboratories | 3 | $62 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Exact Sciences Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
Products named: Ozempic, NURTEC ODT, Wegovy, FREESTYLE LIBRE 3, ELIQUIS, MOUNJARO, FARXIGA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
